You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博拓生物(688767.SH):青石永雋是由浙江大學侵入式腦機接口團隊創辦成立,是南湖腦機交叉研究院首個科技成果轉化企業
格隆匯 08-13 18:25

格隆匯8月13日丨博拓生物(688767.SH)在互動平台表示,公司通過子公司杭州博肽智投企業管理有限公司投資了杭州青石永雋醫療設備有限公司(以下簡稱“青石永雋”),投後佔比5%。青石永雋是由浙江大學侵入式腦機接口團隊創辦成立,是南湖腦機交叉研究院首個科技成果轉化企業,該公司的首款產品面向全球3億抑鬱症患者中近30%的難治性重症抑鬱患者,通過裝備AI算法的三類有源植入醫療器械,為患者提供因人、因病、因時的個性化治療方案。通過手術方式將電極植入患者大腦皮層,接觸腦組織傳遞神經信號,通過植入式腦深部神經刺激(DBS)精準刺激靶點進而達到重大疾病的治療目的。目前已進入科研性臨牀試驗階段,尚未取得醫療器械註冊證書。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account